ATTN LogoMenu
4ANIPTier 5
Articles

ANI PHARMACEUTICALS INC 4

0001938861-26-000021

View on SEC EDGAR

Meredith Cook had 2,466 ANI Pharmaceuticals common shares withheld for taxes upon RSU vesting, retaining 74,924 shares afterward.

On July 18, 2026, Meredith Cook, Sr. VP, General Counsel & Secretary of ANI Pharmaceuticals, Inc., had 2,466 shares of common stock withheld by the company at an implied price of $79.20 per share, totaling approximately $195,307, to cover tax obligations arising from the vesting of 4,820 previously granted restricted stock units. This form of disposition is characterized as an administrative, tax-related transaction under Rule 16(b)-3 rather than an open-market sale and left Cook with direct ownership of 74,924 shares of ANI Pharmaceuticals common stock following the event.

Filing Facts

CIK
1023024
Ticker
ANIP
Form
4
Source Type
fda
Accession
0001938861-26-000021
Alert Tier
5
ANI PHARMACEUTICALS INC 4 | ATTN